|
1
|
Maris JM, Hogarty MD, Bagatell R and Cohn
SL: Neuroblastoma. Lancet. 369:2106–2120. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pastor ER and Mousa SA: Current management
of neuroblastoma and future direction. Crit Rev Oncol Hematol.
138:38–43. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Johnsen JI, Dyberg C and Wickstrom M:
Neuroblastoma-A neural crest derived embryonal malignancy. Front
Mol Neurosci. 12:92019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang M and Weiss WA: Neuroblastoma and
MYCN. Cold Spring Harb Perspect Med. 3:a0144152013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Buechner J and Einvik C: N-myc and
noncoding RNAs in neuroblastoma. Mol Cancer Res. 10:1243–1253.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schulte JH, Horn S, Otto T, Samans B,
Heukamp LC, Eilers UC, Krause M, Astrahantseff K, Klein-Hitpass L,
Buettner R, et al: MYCN regulates oncogenic MicroRNAs in
neuroblastoma. Int J Cancer. 122:699–704. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bray I, Bryan K, Prenter S, Buckley PG,
Foley NH, Murphy DM, Alcock L, Mestdagh P, Vandesompele J, Speleman
F, et al: Widespread dysregulation of miRNAs by MYCN amplification
and chromosomal imbalances in neuroblastoma: Association of miRNA
expression with survival. PLoS One. 4:e78502009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mestdagh P, Fredlund E, Pattyn F, Schulte
JH, Muth D, Vermeulen J, Kumps C, Schlierf S, De Preter K, Van Roy
N, et al: MYCN/c-MYC-induced microRNAs repress coding gene networks
associated with poor outcome in MYCN/c-MYC-activated tumors.
Oncogene. 29:1394–1404. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Babaei K, Shams S, Keymoradzadeh A, Vahidi
S, Hamami P, Khaksar R, Norollahi SE and Samadani AA: An insight of
microRNAs performance in carcinogenesis and tumorigenesis; an
overview of cancer therapy. Life Sci. 240:1170772020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou X, Lu H, Li F, Hao X, Han L, Dong Q
and Chen X: MicroRNA-429 inhibits neuroblastoma cell proliferation,
migration and invasion via the NF-κB pathway. Cell Mol Biol Lett.
25:52020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao X, Gu H, Wang L, Zhang P, Du J, Shen
L, Jiang D, Wang J, Li X, Zhang S, et al: MicroRNA-23a-5p mediates
the proliferation and differentiation of C2C12 myoblasts. Mol Med
Rep. 22:3705–3714. 2020.PubMed/NCBI
|
|
12
|
Tang D, Gao W, Yang J, Liu J, Zhao J, Ge
J, Chen Q and Liu B: miR181d promotes cell proliferation via the
IGF1/PI3K/AKT axis in glioma. Mol Med Rep. 22:3804–3812.
2020.PubMed/NCBI
|
|
13
|
Galardi A, Colletti M, Businaro P,
Quintarelli C, Locatelli F and Di Giannatale A: MicroRNAs in
neuroblastoma: Biomarkers with therapeutic potential. Curr Med
Chem. 25:584–600. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pegtel DM and Gould SJ: Exosomes. Annu Rev
Biochem. 88:487–514. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
McAndrews KM and Kalluri R: Mechanisms
associated with biogenesis of exosomes in cancer. Mol Cancer.
18:522019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun Z, Shi K, Yang S, Liu J, Zhou Q, Wang
G, Song J, Li Z, Zhang Z and Yuan W: Effect of exosomal miRNA on
cancer biology and clinical applications. Mol Cancer. 17:1472018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Morini M, Cangelosi D, Segalerba D,
Marimpietri D, Raggi F, Castellano A, Fruci D, de Mora JF, Canete
A, Yanez Y, et al: Exosomal microRNAs from longitudinal liquid
biopsies for the prediction of response to induction chemotherapy
in high-risk neuroblastoma patients: A proof of concept SIOPEN
Study. Cancers (Basel). 11:14762019. View Article : Google Scholar
|
|
18
|
Ma J, Xu M, Yin M, Hong J, Chen H, Gao Y,
Xie C, Shen N, Gu S and Mo X: Exosomal hsa-miR199a-3p promotes
proliferation and migration in neuroblastoma. Front Oncol.
9:4592019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fonseka P, Liem M, Ozcitti C, Adda CG, Ang
CS and Mathivanan S: Exosomes from N-Myc amplified neuroblastoma
cells induce migration and confer chemoresistance to non-N-Myc
amplified cells: Implications of intra-tumour heterogeneity. J
Extracell Vesicles. 8:15976142019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Paul P, Qiao J, Kim KW, Romain C, Lee S,
Volny N, Mobley B, Correa H and Chung DH: Targeting
gastrin-releasing peptide suppresses neuroblastoma progression via
upregulation of PTEN signaling. PLoS One. 8:e725702013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Purushothaman A: Exosomes from cell
Culture-Conditioned medium: Isolation by ultracentrifugation and
characterization. Methods Mol Biol. 1952:233–244. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zafar A, Wang W, Liu G, Wang X, Xian W,
McKeon F, Foster J, Zhou J and Zhang R: Molecular targeting
therapies for neuroblastoma: Progress and challenges. Med Res Rev.
Nov 6–2020.(Epub ahead of print). doi: 10.1002/med.21750.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Haug BH, Hald ØH, Utnes P, Roth SA, LØkke
C, FlÆgstad T and Einvik C: Exosome-like extracellular vesicles
from MYCN-amplified neuroblastoma cells contain oncogenic miRNAs.
Anticancer Res. 35:2521–2530. 2015.PubMed/NCBI
|
|
25
|
Su T, Xiao Y, Xiao Y, Guo Q, Li C, Huang
Y, Deng Q, Wen J, Zhou F and Luo XH: Bone marrow mesenchymal stem
Cells-Derived Exosomal miR-29b-3p Regulates Aging-Associated
insulin resistance. ACS Nano. 13:2450–2462. 2019.PubMed/NCBI
|
|
26
|
Babuta M, Furi I, Bala S, Bukong TN, Lowe
P, Catalano D, Calenda C, Kodys K and Szabo G: Dysregulated
autophagy and lysosome function are linked to exosome production by
Micro-RNA 155 in alcoholic liver disease. Hepatology. 70:2123–2141.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Loven J, Zinin N, Wahlstrom T, Muller I,
Brodin P, Fredlund E, Ribacke U, Pivarcsi A, Pahlman S and
Henriksson M: MYCN-regulated microRNAs repress estrogen
receptor-alpha (ESR1) expression and neuronal differentiation in
human neuroblastoma. Proc Natl Acad Sci USA. 107:1553–1558. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Khuu C, Utheim TP and Sehic A: The three
paralogous MicroRNA clusters in development and disease, miR-17-92,
miR-106a-363, and miR-106b-25. Scientifica (Cairo).
2016:13796432016.PubMed/NCBI
|
|
29
|
Opel D, Poremba C, Simon T, Debatin KM and
Fulda S: Activation of Akt predicts poor outcome in neuroblastoma.
Cancer Res. 67:735–745. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hogarty MD and Maris JM: PI3King on MYCN
to improve neuroblastoma therapeutics. Cancer Cell. 21:145–147.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Z, Xie J, Fei Y, Gao P, Xie Q, Gao W
and Xu Z: GDNF family receptor alpha 2 promotes neuroblastoma cell
proliferation by interacting with PTEN. Biochem Biophys Res Commun.
510:339–344. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee YR, Chen M and Pandolfi PP: The
functions and regulation of the PTEN tumour suppressor: New modes
and prospects. Nat Rev Mol Cell Biol. 19:547–562. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu Q, Shang Y, Shen T, Liu F, Xu Y and
Wang H: Neuroprotection of miR-214 against isoflurane-induced
neurotoxicity involves the PTEN/PI3K/Akt pathway in human
neuroblastoma cell line SH-SY5Y. Arch Biochem Biophys.
678:1081812019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gerlinger M, Rowan AJ, Horswell S, Math M,
Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N,
Stewart A, et al: Intratumor heterogeneity and branched evolution
revealed by multiregion sequencing. N Engl J Med. 366:883–892.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Barranha R, Costa JL, Carneiro F and
Machado JC: Genetic heterogeneity in colorectal cancer and its
clinical implications. Acta Med Port. 28:370–375. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lu R, Zhao G, Yang Y, Jiang Z, Cai J,
Zhang Z and Hu H: Long noncoding RNA HOTAIRM1 inhibits cell
progression by regulating miR-17-5p/ PTEN axis in gastric cancer. J
Cell Biochem. 120:4952–4965. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liang W and Yue Z: Lycium barbarum
polysaccharides promote osteoblasts viability by regulating
microRNA-17/PTEN. Life Sci. 225:72–78. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang X, Li Z, Bai J, Song W and Zhang F:
miR-17-5p regulates the proliferation and apoptosis of human
trabecular meshwork cells by targeting phosphatase and tensin
homolog. Mol Med Rep. 19:3132–3138. 2019.PubMed/NCBI
|
